Work

33557 Dupilumab treatment restores skin barrier function and improves clinical and patient reported outcomes in adults and adolescents with moderate to severe atopic dermatitis

Year: 2022

Type: article

Study design: Clinical Trial

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2022.06.670

Authors: Robert Bissonnette, Donald Y.M. Leung, Gabriel Bologna, Noah A. Levit, Ana B. Rossi, Annie Zhang

Institutions: Innovaderm (Canada), National Jewish Health, Regeneron (United States)

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4295255437

FWCI: 0.202

Cites:

Cited by: 1

Related to: 10